Downregulation of TAB182 Promotes Cancer Stem-Like Cell Properties and Therapeutic Resistance in Triple-Negative Breast Cancer Cells
The authors revealed a novel function of TAB182 as a potential negative regulator of cancer stem-like properties and drug sensitivity in triple-negative breast cancer cells.
[Biogerontology] Investigators explored the possibility of inducing aging-associated features in cell types of the central nervous system using hiPSC technology.
[Journal Of Neuroscience] The authors reported using human tumor specimens and primary spheroids from male and female patients that GlialCAM, was differentially expressed in subpopulations of glioblastoma cells.
[Molecular Psychiatry] Investigators showed that the PTENG132D allele disrupted early neuroectoderm formation during the first several days of organoid generation, and results in deficient electrophysiology.